10 results on '"Haribabu, Hemalatha"'
Search Results
2. Effect of Metformin on Plasma Exposure of Rifampicin, Isoniazid, and Pyrazinamide in Patients on Treatment for Pulmonary Tuberculosis
- Author
-
Kumar, Agibothu Kupparam Hemanth, Kadam, Abhijit, Karunaianantham, Ramesh, Tamizhselvan, Manoharan, Padmapriyadarsini, Chandrasekaran, Mohan, Anant, Jeyadeepa, B., Radhakrishnan, Ammayappan, Singh, Urvashi B., Bapat, Shraddha, Mane, Aarti, Kumar, Pradeep, Mamulwar, Megha, Bhavani, Perumal Kannabiran, Haribabu, Hemalatha, Rath, Nibedita, Guleria, Randeep, Khan, Abdul Mabood, and Menon, Jaykumar
- Published
- 2023
- Full Text
- View/download PDF
3. Molecular characterisation of the pol gene of vertically transmitted HIV-1 strains in children with virological failure
- Author
-
Karunaianantham, Ramesh, primary, Nesakumar, Manohar, additional, Gopalan, Bindu, additional, Haribabu, Hemalatha, additional, Hanna, Luke E, additional, Sanjeeva, GN, additional, Reddy, Devarajulu, additional, Shet, Anita, additional, SWAMINATHAN, SOUMYA, additional, and Padmapriyadarsini, Chandrasekaran, additional
- Published
- 2022
- Full Text
- View/download PDF
4. Role of LTA4H Polymorphism in Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Occurrence and Clinical Severity in Patients Infected with HIV.
- Author
-
Gopalan Narendran, Dhanasekaran Kavitha, Ramesh Karunaianantham, Leonardo Gil-Santana, Jilson L Almeida-Junior, Sirasanambatti Devarajulu Reddy, Marimuthu Makesh Kumar, Haribabu Hemalatha, Nagesh Nalini Jayanthi, Narayanan Ravichandran, Raja Krishnaraja, Angamuthu Prabhakar, Tamizhselvan Manoharan, Lokeswaran Nithyananthan, Gunasundari Arjunan, Mohan Natrajan, Soumya Swaminathan, and Bruno B Andrade
- Subjects
Medicine ,Science - Abstract
BACKGROUND:Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) is an inflammatory phenomenon complicating HIV management in coincidental tuberculosis (TB) infection, upon immune reconstitution driven by antiretroviral therapy (ART). Leukotriene A4 hydroxylase (LTA4H), an enzyme which converts LTA4 to LTB4, regulates the balance between the anti-inflammatory lipoxins and pro-inflammatory LTB4, with direct implications in TB-driven inflammation. In humans, a single nucleotide polymorphism (SNP) in the LTA4H promoter which regulates its transcriptional activity (rs17525495) has been identified and described to impact clinical severity of TB presentation and response to corticosteroid therapy. Notably, the role of LTA4H on TB-IRIS has not been previously evaluated. Here, we performed an exploratory investigation testing the association of LTA4H polymorphism with respect to frequency of TB-IRIS occurrence and severity of TB-IRIS presentation in HIV-TB co-infected individuals. METHODS:Genotypic evaluation of the LTA4H enzyme from available samples was retrospectively correlated with clinical data captured in case sheets including IRIS details. The cohort included patients recruited from a prospective cohort study nested within a randomized clinical trial (NCT0933790) of ART-naïve HIV+ patients with newly diagnosed rifampicin sensitive pulmonary TB in South India. Frequency of the wild type genotype (CC), as well as of the mutant genotypes (CT or TT) in the IRIS and non-IRIS patients was estimated. Comparative analyses were performed between wild genotype (CC) and the mutant genotypes (CT or TT) and tested for association between the LTA4H polymorphisms and IRIS incidence and clinical severity. RESULTS:A total of 142 eligible ART-naïve patients were included in the analyses. Eighty-six individuals exhibited the wild genotype (CC) while 56 had mutant genotypes (43-CT and only 13-TT). Variant allele frequency was 0.23 and 0.26 in non-IRIS group and in IRIS group, respectively. Upon ART initiation, 51 patients developed IRIS while 91 did not. IRIS incidence was 34% and 37% in the wild (CC) and mutant type (CT/TT), respectively (p = 0.858) with a higher frequency of severe IRIS presentation in the mutant genotype group compared to the wild type genotype (p = 0.0006). A logistic regression model confirmed the association between the presence of CT/TT genotypes and occurrence of severe IRIS. Corticosteroid therapy successfully resolved IRIS in all cases irrespective of the LTA4H genotype. CONCLUSION:A higher incidence of severe IRIS among patients with mutant LTA4H genotypes (CT and TT) was observed compared to the wild type, despite similar IRIS incidence and immune restoration in both groups. Steroids were effective in alleviating IRIS in all the genotypes.
- Published
- 2016
- Full Text
- View/download PDF
5. Genetic Characterization of Full-Length HIV-2 Long Terminal Repeat Sequences: Identification of Rare Promoter Variants
- Author
-
Haribabu Hemalatha, Luke Elizabeth Hanna, Kailapuri G. Murugavel, K K Vidyavijayan, Sathiaseelan Manohar Nesakumar, K. Ramesh, Karunakaran Lucia Precilla, and Srikanth Tripathy
- Subjects
Adult ,Male ,Adolescent ,Transcription, Genetic ,Immunology ,India ,HIV Infections ,Biology ,Virus Replication ,Proviruses ,Transcription (biology) ,Virology ,Humans ,Binding site ,Enhancer ,Promoter Regions, Genetic ,Transcription factor ,Phylogeny ,Sequence (medicine) ,HIV Long Terminal Repeat ,Genetics ,Phylogenetic tree ,NF-kappa B ,Genetic Variation ,Middle Aged ,Subtyping ,Long terminal repeat ,Infectious Diseases ,HIV-2 ,Female - Abstract
In this study, we sequenced the full-length HIV type 2 (HIV-2) long terminal repeat region from the proviral DNA of 23 HIV-2-infected individuals from the southern parts of India. We identified two different promoter variant strains circulating in this region along with the globally circulating common promoter variant. Seven sequences had an additional nuclear factor kappa-light chain enhancer of activated B cells (NF-κB) binding motif and the sequence from another subject showed one NF-κB and one RBE-III binding site. Phylogenetic and subtyping analyses revealed that the circulating strains comprised HIV-2 subtype A. The occurrence of two NF-κB binding sites in ∼30% of the sequences analyzed in our study prompts us to hypothesize that as in the case of HIV-1 subtype C viruses that possess additional κB sites, the two NF-κB HIV-2 variants might possess superior replication fitness because of the increased magnitude of transcription, thus leading to the expansion of these variants in the country.
- Published
- 2020
6. Transmitted HIV-1 Drug Resistance in a Treatment-Naive Cohort of Recently Infected Individuals from Chennai, India
- Author
-
Nesakumar, Manohar, primary, Haribabu, Hemalatha, additional, Cheedarla, Narayanaiah, additional, Karunaianantham, Ramesh, additional, Kailasam, Nandagopal, additional, Sathyamurthi, Pattabiraman, additional, Selvachithiram, Murugesan, additional, Tripathy, Srikanth Prasad, additional, and Hanna, Luke Elizabeth, additional
- Published
- 2019
- Full Text
- View/download PDF
7. Role of LTA4H Polymorphism in Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Occurrence and Clinical Severity in Patients Infected with HIV
- Author
-
Nagesh Nalini Jayanthi, Ramesh Karunaianantham, Sirasanambatti Devarajulu Reddy, Gunasundari Arjunan, G. Narendran, Dhanasekaran Kavitha, Soumya Swaminathan, Raja Krishnaraja, Angamuthu Prabhakar, Marimuthu Makesh Kumar, Leonardo Gil-Santana, Lokeswaran Nithyananthan, Jilson L. Almeida-Junior, Haribabu Hemalatha, Narayanan Ravichandran, Tamizhselvan Manoharan, Mohan Natrajan, and Bruno B. Andrade
- Subjects
0301 basic medicine ,Bacterial Diseases ,RNA viruses ,Male ,Heredity ,Human immunodeficiency virus (HIV) ,lcsh:Medicine ,HIV Infections ,medicine.disease_cause ,Pathology and Laboratory Medicine ,urologic and male genital diseases ,Biochemistry ,Severity of Illness Index ,Steroid Therapy ,White Blood Cells ,0302 clinical medicine ,Immunodeficiency Viruses ,Animal Cells ,Medicine and Health Sciences ,Medicine ,Clinical severity ,030212 general & internal medicine ,Promoter Regions, Genetic ,lcsh:Science ,Immune Response ,Epoxide Hydrolases ,Multidisciplinary ,T Cells ,Organic Compounds ,Pharmaceutics ,Middle Aged ,Genetic Mapping ,Chemistry ,Infectious Diseases ,Medical Microbiology ,Viral Pathogens ,Viruses ,Physical Sciences ,Steroids ,Female ,Pathogens ,Cellular Types ,Research Article ,Adult ,Tuberculosis ,Immune Cells ,Immunology ,Variant Genotypes ,Microbiology ,Polymorphism, Single Nucleotide ,03 medical and health sciences ,Signs and Symptoms ,Immune reconstitution inflammatory syndrome ,Drug Therapy ,Diagnostic Medicine ,Severity of illness ,Retroviruses ,Genetics ,Humans ,In patient ,Hemoglobin ,cardiovascular diseases ,Microbial Pathogens ,Inflammation ,Blood Cells ,business.industry ,urogenital system ,Lentivirus ,Organic Chemistry ,lcsh:R ,Organisms ,Chemical Compounds ,Biology and Life Sciences ,HIV ,Proteins ,Cell Biology ,medicine.disease ,Tropical Diseases ,030104 developmental biology ,Steroid therapy ,lcsh:Q ,business - Abstract
Background Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) is an inflammatory phenomenon complicating HIV management in coincidental tuberculosis (TB) infection, upon immune reconstitution driven by antiretroviral therapy (ART). Leukotriene A4 hydroxylase (LTA4H), an enzyme which converts LTA4 to LTB4, regulates the balance between the anti-inflammatory lipoxins and pro-inflammatory LTB4, with direct implications in TB-driven inflammation. In humans, a single nucleotide polymorphism (SNP) in the LTA4H promoter which regulates its transcriptional activity (rs17525495) has been identified and described to impact clinical severity of TB presentation and response to corticosteroid therapy. Notably, the role of LTA4H on TB-IRIS has not been previously evaluated. Here, we performed an exploratory investigation testing the association of LTA4H polymorphism with respect to frequency of TB-IRIS occurrence and severity of TB-IRIS presentation in HIV-TB co-infected individuals. Methods Genotypic evaluation of the LTA4H enzyme from available samples was retrospectively correlated with clinical data captured in case sheets including IRIS details. The cohort included patients recruited from a prospective cohort study nested within a randomized clinical trial (NCT0933790) of ART-naïve HIV+ patients with newly diagnosed rifampicin sensitive pulmonary TB in South India. Frequency of the wild type genotype (CC), as well as of the mutant genotypes (CT or TT) in the IRIS and non-IRIS patients was estimated. Comparative analyses were performed between wild genotype (CC) and the mutant genotypes (CT or TT) and tested for association between the LTA4H polymorphisms and IRIS incidence and clinical severity. Results A total of 142 eligible ART-naïve patients were included in the analyses. Eighty-six individuals exhibited the wild genotype (CC) while 56 had mutant genotypes (43-CT and only 13-TT). Variant allele frequency was 0.23 and 0.26 in non-IRIS group and in IRIS group, respectively. Upon ART initiation, 51 patients developed IRIS while 91 did not. IRIS incidence was 34% and 37% in the wild (CC) and mutant type (CT/TT), respectively (p = 0.858) with a higher frequency of severe IRIS presentation in the mutant genotype group compared to the wild type genotype (p = 0.0006). A logistic regression model confirmed the association between the presence of CT/TT genotypes and occurrence of severe IRIS. Corticosteroid therapy successfully resolved IRIS in all cases irrespective of the LTA4H genotype. Conclusion A higher incidence of severe IRIS among patients with mutant LTA4H genotypes (CT and TT) was observed compared to the wild type, despite similar IRIS incidence and immune restoration in both groups. Steroids were effective in alleviating IRIS in all the genotypes.
- Published
- 2016
8. N-acetyltransferase gene polymorphisms & plasma isoniazid concentrations in patients with tuberculosis
- Author
-
Ramachandran, Geetha, primary, Hemanth Kumar, AK, additional, Ramesh, K, additional, Kannan, T, additional, Sudha, V, additional, Haribabu, Hemalatha, additional, Lavanya, J, additional, and Swaminathan, Soumya, additional
- Published
- 2017
- Full Text
- View/download PDF
9. N-acetyltransferase gene polymorphisms & plasma isoniazid concentrations in patients with tuberculosis.
- Author
-
Kumar, A. K. Hemanth, Ramesh, K., Kannan, T., Sudha, V., Haribabu, Hemalatha, Lavanya, J., Swaminathan, Soumya, and Ramachandran, Geetha
- Subjects
- *
ISONIAZID , *BLOOD plasma , *ACETYLTRANSFERASES , *GENETIC polymorphisms , *TUBERCULOSIS patients , *PUBLIC health , *THERAPEUTICS - Abstract
Background & objectives: Variations in the N-acetyltransferase (NAT2) gene among different populations could affect the metabolism and disposition of isoniazid (INH). This study was performed to genotype NAT2 gene polymorphisms in tuberculosis (TB) patients from Chennai, India, and compare plasma INH concentrations among the different genotypes. Methods: Adult patients with TB treated in the Revised National TB Control Programme (RNTCP) in Chennai, Tamil Nadu, were genotyped for NAT2 gene polymorphism, and two-hour post-dosing INH concentrations were compared between the different genotypes. Plasma INH was determined by highperformance liquid chromatography. Genotyping of the NAT2 gene polymorphism was performed by real-time polymerase chain reaction method. Results: Among the 326 patients genotyped, there were 189 (58%), 114 (35%) and 23 (7%) slow, intermediate and fast acetylators, respectively. The median two-hour INH concentrations in slow, intermediate and fast acetylators were 10.2, 8.1 and 4.1 µg/ml, respectively. The differences in INH concentrations among the three genotypes were significant (P≺0.001). Interpretation & conclusions: Genotyping of TB patients from south India for NAT2 gene polymorphism revealed that 58 per cent of the study population comprised slow acetylators. Two-hour INH concentrations differed significantly among the three genotypes. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
10. N-acetyltransferase gene polymorphisms & plasma isoniazid concentrations in patients with tuberculosis.
- Author
-
Hemanth Kumar AK, Ramesh K, Kannan T, Sudha V, Haribabu H, Lavanya J, Swaminathan S, and Ramachandran G
- Subjects
- Adult, Female, Genotype, Humans, Isoniazid therapeutic use, Male, Middle Aged, Tuberculosis drug therapy, Tuberculosis genetics, Tuberculosis pathology, Arylamine N-Acetyltransferase genetics, Inactivation, Metabolic genetics, Isoniazid blood, Tuberculosis blood
- Abstract
Background & Objectives: Variations in the N-acetyltransferase (NAT2) gene among different populations could affect the metabolism and disposition of isoniazid (INH). This study was performed to genotype NAT2 gene polymorphisms in tuberculosis (TB) patients from Chennai, India, and compare plasma INH concentrations among the different genotypes., Methods: Adult patients with TB treated in the Revised National TB Control Programme (RNTCP) in Chennai, Tamil Nadu, were genotyped for NAT2 gene polymorphism, and two-hour post-dosing INH concentrations were compared between the different genotypes. Plasma INH was determined by high-performance liquid chromatography. Genotyping of the NAT2 gene polymorphism was performed by real-time polymerase chain reaction method., Results: Among the 326 patients genotyped, there were 189 (58%), 114 (35%) and 23 (7%) slow, intermediate and fast acetylators, respectively. The median two-hour INH concentrations in slow, intermediate and fast acetylators were 10.2, 8.1 and 4.1 μg/ml, respectively. The differences in INH concentrations among the three genotypes were significant (P<0.001)., Interpretation & Conclusions: Genotyping of TB patients from south India for NAT2 gene polymorphism revealed that 58 per cent of the study population comprised slow acetylators. Two-hour INH concentrations differed significantly among the three genotypes.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.